/
/
/

Concord Biotech Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)1,548.50
Volume (₹)3.18 L
High (₹)1,548.50
Upper Circuit1,872.30
Low (₹)1,472.70
Lower Circuit1,248.30
Prev Close1,560.30
52W High (₹)1,667.60
Price1,478.80
52W Low (₹)987.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)16311.80 Cr
Div. Yield (%)0.48
PE Ratio59.23
Debt to Equity0.00
Price to Book5.27
Book Value192.81
EPS (TTM)26.32
Face Value1.00
ROE (%)13.54

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
CONCORDBIONSE
LTP
1W Low
1W High
Market cap (₹)
1849.9+12.6 (0.69%)
1832.20
1891.50
4,47,476Cr
9602+227 (2.42%)
9312.50
9740
2,54,764Cr
4928.5+88.5 (1.83%)
4848.50
5010
1,89,423Cr
1180.3+20.3 (1.75%)
1152.10
1190.60
1,16,658Cr
1399+4.5 (0.32%)
1364.50
1419
1,11,484Cr
2026.2+72.2 (3.69%)
1963.80
2055.30
1,09,943Cr
2500+199.3 (8.66%)
2303
2504.30
1,01,712Cr
1200.4+15.4 (1.30%)
1185
1222
1,01,005Cr
1716-18 (-1.04%)
1689.30
1740
99,253Cr
2100.7+17.7 (0.85%)
2080
2135
96,031Cr
1478.8-15.6 (-1.04%)
1472.70
1592
16,312Cr

Key Highlights of Concord Biotech Ltd Balance Sheet

Concord Biotech Ltd balance sheet discloses shareholders' funds of ₹10.46Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹10.46Cr, and the reserves and surplus of the company is ₹2009.29Cr.

The company has its non-current liabilities with total liabilities of ₹2236.54Cr as of 2026-03-31.

The current liabilities are ₹167.25Cr as of 2026-03-31. At the same time, current assets are ₹1245.22Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹85.63Cr and tangible assets of ₹786.41Cr, provided in the Concord Biotech Ltd financial statements.